Sysmex Corp
TSE:6869
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 166.8315
3 177
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Sysmex Corp
Sysmex Corp
Net Issuance of Common Stock
Sysmex Corp
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sysmex Corp
TSE:6869
|
Net Issuance of Common Stock
-¥11.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Terumo Corp
TSE:4543
|
Net Issuance of Common Stock
-¥13.4B
|
CAGR 3-Years
-1 395%
|
CAGR 5-Years
-353%
|
CAGR 10-Years
-97%
|
|
|
Olympus Corp
TSE:7733
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nihon Kohden Corp
TSE:6849
|
Net Issuance of Common Stock
-¥1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-308%
|
CAGR 10-Years
N/A
|
|
|
JEOL Ltd
TSE:6951
|
Net Issuance of Common Stock
¥0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fukuda Denshi Co Ltd
TSE:6960
|
Net Issuance of Common Stock
-¥11.2B
|
CAGR 3-Years
-2 141%
|
CAGR 5-Years
-546%
|
CAGR 10-Years
-7%
|
|
Sysmex Corp
Glance View
Sysmex Corporation, a global leader in healthcare and diagnostics, specializes in innovative laboratory solutions and instruments that enhance patient care and streamline clinical workflows. Established in 1968 and headquartered in Kobe, Japan, Sysmex has evolved from a domestic player to an international powerhouse, with a presence in over 190 countries. With a steadfast commitment to research and development, the company focuses on hematology, immunochemistry, and molecular diagnostics, continually pushing the boundaries of technology. Their flagship products, which include advanced analyzers and systems, empower healthcare professionals to make timely and accurate clinical decisions, ultimately improving patient outcomes across the globe. For investors, Sysmex embodies a compelling growth story in the ever-expanding healthcare market. The aging population and increasing prevalence of chronic diseases drive demand for diagnostic solutions, positioning Sysmex to capitalize on these trends. The company’s robust financial performance is evidenced by consistent revenue growth and a strong balance sheet, supported by strategic collaborations and a diverse product portfolio. With a commitment to sustainability and social responsibility, Sysmex not only prioritizes profitability but also aims to contribute positively to global health challenges. As the world increasingly relies on advanced diagnostics, Sysmex stands out as a forward-thinking investment opportunity that combines financial stability with a meaningful social impact.
See Also
What is Sysmex Corp's Net Issuance of Common Stock?
Net Issuance of Common Stock
-11.7B
JPY
Based on the financial report for Sep 30, 2024, Sysmex Corp's Net Issuance of Common Stock amounts to -11.7B JPY.
You don't have any saved screeners yet
